166 related articles for article (PubMed ID: 19151749)
1. The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells.
Zhou Q; Geahlen RL
Oncogene; 2009 Mar; 28(10):1348-56. PubMed ID: 19151749
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase.
Takada Y; Mukhopadhyay A; Kundu GC; Mahabeleshwar GH; Singh S; Aggarwal BB
J Biol Chem; 2003 Jun; 278(26):24233-41. PubMed ID: 12711606
[TBL] [Abstract][Full Text] [Related]
3. Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6.
Wu NL; Huang DY; Tsou HN; Lin YC; Lin WW
J Invest Dermatol; 2015 Feb; 135(2):490-498. PubMed ID: 25202827
[TBL] [Abstract][Full Text] [Related]
4. TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-kappaB activation, and apoptosis.
Takada Y; Aggarwal BB
J Immunol; 2004 Jul; 173(2):1066-77. PubMed ID: 15240695
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
6. Modulation by Syk of Bcl-2, calcium and the calpain-calpastatin proteolytic system in human breast cancer cells.
Fei B; Yu S; Geahlen RL
Biochim Biophys Acta; 2013 Oct; 1833(10):2153-64. PubMed ID: 23684705
[TBL] [Abstract][Full Text] [Related]
7. Tetramethylpyrazine attenuates TNF-α-induced iNOS expression in human endothelial cells: Involvement of Syk-mediated activation of PI3K-IKK-IκB signaling pathways.
Zheng Z; Li Z; Chen S; Pan J; Ma X
Exp Cell Res; 2013 Aug; 319(14):2145-51. PubMed ID: 23726836
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolic acid regulates spleen tyrosine kinase to repress tumour necrosis factor-alpha-induced monocyte chemotatic protein-1 production in cultured human aortic endothelial cells.
Koo TY; Kim YJ; Yang WS; Park JS; Han NJ; Lee JM; Park SK
Cell Biol Int; 2013 Jan; 37(1):19-28. PubMed ID: 23319318
[TBL] [Abstract][Full Text] [Related]
9. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.
Chakraborty G; Rangaswami H; Jain S; Kundu GC
J Biol Chem; 2006 Apr; 281(16):11322-31. PubMed ID: 16474166
[TBL] [Abstract][Full Text] [Related]
11. Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages.
Sun H; Xu XY; Tian XL; Shao HT; Wu XD; Wang Q; Su X; Shi Y
Immunobiology; 2014 Jan; 219(1):25-36. PubMed ID: 23886693
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor.
Regamey A; Hohl D; Liu JW; Roger T; Kogerman P; Toftgard R; Huber M
J Exp Med; 2003 Dec; 198(12):1959-64. PubMed ID: 14676304
[TBL] [Abstract][Full Text] [Related]
13. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation.
Ashikawa K; Majumdar S; Banerjee S; Bharti AC; Shishodia S; Aggarwal BB
J Immunol; 2002 Dec; 169(11):6490-7. PubMed ID: 12444159
[TBL] [Abstract][Full Text] [Related]
14. High glucose-induced NF-kappaB activation occurs via tyrosine phosphorylation of IkappaBalpha in human glomerular endothelial cells: involvement of Syk tyrosine kinase.
Yang WS; Seo JW; Han NJ; Choi J; Lee KU; Ahn H; Lee SK; Park SK
Am J Physiol Renal Physiol; 2008 May; 294(5):F1065-75. PubMed ID: 18353872
[TBL] [Abstract][Full Text] [Related]
15. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
16. IL-1 induced chemokine production through the association of Syk with TNF receptor-associated factor-6 in nasal fibroblast lines.
Yamada T; Fujieda S; Yanagi S; Yamamura H; Inatome R; Yamamoto H; Igawa H; Saito H
J Immunol; 2001 Jul; 167(1):283-8. PubMed ID: 11418661
[TBL] [Abstract][Full Text] [Related]
17. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine kinase Syk regulates TPL2 activation signals.
Eliopoulos AG; Das S; Tsichlis PN
J Biol Chem; 2006 Jan; 281(3):1371-80. PubMed ID: 16291755
[TBL] [Abstract][Full Text] [Related]
19. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer].
Chen XL; Li L; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204
[TBL] [Abstract][Full Text] [Related]
20. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.
Lee SY; Lee SY; Choi Y
J Exp Med; 1997 Apr; 185(7):1275-85. PubMed ID: 9104814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]